Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1450754-37-6

Post Buying Request

1450754-37-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1450754-37-6 Usage

Description

3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)propanoic acid is a trifunctional building block used for chemical probe synthesis. It contains a light-activated diazirine, an alkyne tag, and a carboxylic acid synthetic handle, which enable various interactions and modifications in chemical biology experiments.

Uses

Used in Chemical Probe Synthesis:
3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)propanoic acid is used as a building block for chemical probe synthesis due to its trifunctional nature, which includes a light-activated diazirine, alkyne tag, and carboxylic acid synthetic handle. This allows for UV light-induced covalent modification of a biological target with potential for downstream applications via the alkyne tag.
Used in Chemical Biology Experiments:
In the field of chemical biology, 3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)propanoic acid is used as a versatile building block to discover the optimal probe for various experiments. It can be used alone or in parallel with other multi-functional building blocks to enhance the understanding of biological processes and develop new therapeutic strategies.
Used in Drug Development:
3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)propanoic acid can be employed in the development of new drugs, particularly in the field of cancer research. Its light-activated diazirine and alkyne tag functionalities allow for targeted covalent modification of cancer-related proteins or other biological targets, potentially leading to the development of more effective and selective therapeutic agents.
Used in Drug Delivery Systems:
Similar to gallotannin, 3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)propanoic acid can be incorporated into drug delivery systems to improve the delivery, bioavailability, and therapeutic outcomes of various drugs. Its unique functional groups can be exploited to enhance the specificity and efficacy of drug delivery, particularly in the context of cancer treatment.

Check Digit Verification of cas no

The CAS Registry Mumber 1450754-37-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,5,0,7,5 and 4 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1450754-37:
(9*1)+(8*4)+(7*5)+(6*0)+(5*7)+(4*5)+(3*4)+(2*3)+(1*7)=156
156 % 10 = 6
So 1450754-37-6 is a valid CAS Registry Number.

1450754-37-6Relevant articles and documents

Chemical Probes Reveal Sirt2's New Function as a Robust "eraser" of Lysine Lipoylation

Xie, Yusheng,Chen, Lanfang,Wang, Rui,Wang, Jigang,Li, Jingyu,Xu, Wei,Li, Yingxue,Yao, Shao Q.,Zhang, Liang,Hao, Quan,Sun, Hongyan

, p. 18428 - 18436 (2019)

Lysine lipoylation, a highly conserved lysine post-translational modification, plays a critical role in regulating cell metabolism. The catalytic activity of a number of vital metabolic proteins, such as pyruvate dehydrogenase (PDH), depends on lysine lipoylation. Despite its important roles, the detailed biological regulatory mechanism of lysine lipoylation remains largely unexplored. Herein we designed a powerful affinity-based probe, KPlip, to interrogate the interactions of lipoylated peptide/proteins under native cellular environment. Large-scale chemical proteomics analysis revealed a number of binding proteins of KPlip, including sirtuin 2 (Sirt2), an NAD+-dependent protein deacylase. To explore the potential activity of Sirt2 toward lysine lipoylation, we designed a single-step fluorogenic probe, KTlip, which reports delipoylation activity in a continuous manner. The results showed that Sirt2 led to significant delipoylation of KTlip, displaying up to a 60-fold fluorescence increase in the assay. Further kinetic experiments with different peptide substrates revealed that Sirt2 can catalyze the delipoylation of peptide (DLAT-PDH, K259) with a remarkable catalytic efficiency (kcat/Km) of 3.26 × 103 s-1 M-1. The activity is about 400-fold higher than that of Sirt4, the only mammalian enzyme with known delipoylation activity. Furthermore, overexpression and silencing experiments demonstrated that Sirt2 regulates the lipoylation level and the activity of endogenous PDH, thus unequivocally confirming that PDH is a genuine physiological substrate of Sirt2. Using our chemical probes, we have successfully established the relationship between Sirt2 and lysine lipoylation in living cells for the first time. We envision that such chemical probes will serve as useful tools for delineating the roles of lysine lipoylation in biology and diseases.

One-Pot Synthesis of Diazirines and 15N2-Diazirines from Ketones, Aldehydes and Derivatives: Development and Mechanistic Insight

Ibert, Quentin,Cauwel, Madeleine,Glachet, Thomas,Tite, Tony,Le Nahenec-Martel, Patricia,Lohier, Jean-Fran?ois,Renard, Pierre-Yves,Franck, Xavier,Reboul, Vincent,Sabot, Cyrille

supporting information, p. 4390 - 4398 (2021/08/03)

Broad scope one-pot diazirine synthesis strategies have been developed using two different oxidants depending on the nature of the starting material. In all cases, an inexpensive commercial solution of ammonia (NH3) in methanol (MeOH) was emplo

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

-

, (2019/02/13)

In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured.The variables shown in Formula AA are as defined in the claims. The compounds of formula AA are NLRP3 activity modulators and, as such, can be used in the treatment of metabolic disorders (e.g. Type 2 diabetes, atherosclerosis, obesity or gout), a disease of the central nervous system (e.g. Alzheimer's disease, multiple sclerosis, Amyotrophic Lateral Sclerosis or Parkinson's disease), lung disease (e.g. asthma, COPD or pulmonary idiopathic fibrosis), liver disease (e.g. NASH syndrome, viral hepatitis or cirrhosis), pancreatic disease (e.g. acute pancreatitis or chronic pancreatitis), kidney disease (e.g. acute kidney injury or chronic kidney injury), intestinal disease (e.g. Crohn's disease or Ulcerative Colitis), skin disease (e.g. psoriasis), musculoskeletal disease (e.g. scleroderma), a vessel disorder (e.g. giant cell arteritis), a disorder of the bones (e.g. osteoarthritis, osteoporosis or osteopetrosis disorders), eye disease (e.g. glaucoma or macular degeneration), a disease caused by viral infection (e.g. HIV or AIDS), an autoimmune disease (e.g. Rheumatoid Arthritis, Systemic Lupus Erythematosus or Autoimmune Thyroiditis), cancer or aging.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1450754-37-6